Life Sciences
Top stories summarized by our editors
11/13/2018

CStone Pharmaceuticals proposed to list an initial public offering on the Hong Kong stock exchange. The company has an ongoing late-stage study of CS1001 in China for non-small cell lung cancer, and intends to launch Phase III trials for stage 4 NSCLC by the end of this year and trials for hepatocellular carcinoma and gastric cancer in the first half of next year.

Full Story:
BioCentury
11/13/2018

Researchers from Rice University used CRISPR-Cas9 technology to modify a baculovirus, based on a virus that affects moths, because it can carry up to eight times more DNA pairs than other viral delivery methods. In the study, baculovirus vectors are loaded with the immune system protein C3, which allows the researchers to inactivate and reactivate the virus using a magnetic field to deliver treatments precisely where they are needed.

Full Story:
New Atlas
More Summaries:
Rice University
11/13/2018

A quarterly report published by the UK Department for Transport indicated that 525 million liters of renewable fuel were supplied between April 15 and Sept. 17, of which 172 million liters met the UK's sustainability requirements.

11/13/2018

The latest ad campaign from the American Lung Association resembles a true crime show and is aimed at women. The ads will run during true crime shows and podcasts.

Full Story:
MM&M
More Summaries:
American Lung Association
11/13/2018

Tobacco-related health care costs are more than $7 billion in Minnesota, according to an ad campaign by ClearWay Minnesota and agency Haberman. The campaign notes that teen smoking rates are increasing, mainly because of e-cigarettes.

More Summaries:
Haberman
11/13/2018

A round of financing led by Australian implantable hearing solutions firm Cochlear has brought in $17.1 million for Belgium-based Nyxoah, which makes a hypoglossal nerve stimulation therapy to treat obstructive sleep apnea. Nyxoah will use the money for post-CE mark market-development programs in Europe, as well as to seek investigational device exemption from the FDA.

Full Story:
Globes (Israel)
More Summaries:
Nyxoah, Cochlear, FDA
11/13/2018

A round of financing has brought in $17 million for Aegea Medical, which makes the Adaptive Vapor Ablation technology. The proceeds will be used to advance a prospective, multicenter study and to release its technology for minimally invasive treatment of heavy menstrual bleeding next year.

Full Story:
FinSMEs
More Summaries:
Aegea Medical
11/13/2018

NuVasive saw 10.2% year-over-year revenue growth in the third quarter, topping the orthopedic device companies that recently reported earnings. Stryker followed with 7.9% organic, constant currency revenue growth, while Johnson & Johnson saw near flat orthopedic device sales.

More Summaries:
Johnson & Johnson, NuVasive, Stryker
11/13/2018

A PwC report predicts the health care industry will overtake other industries in terms of research and development spending by 2020. The health care industry, which currently ranks second in R&D spending after the computing and electronics industry, has 23 companies listed in the report as "high leverage innovators" for 2017, including Medtronic, Hologic and Fresenius Medical Care.

Full Story:
Healthcare Finance
11/13/2018

Research Reports predicts the worldwide market for surgical navigation systems will see a compound annual growth rate of 4.4% through 2023, with the US market hitting $780 million. Key market players include Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, Brainlab and XION.

Full Story:
Becker's Spine Review